PharmaLex US experts review FDA – EU authorities’ Mutual Recognition Agreement

During March 2017 the FDA and EU authorities signed the Mutual Recognition Agreement, an amendment to the annex for Good Manufacturing Practice (GMP) to the broader US – EU Mutual Recognition Act previously signed in 1998.  This update will allow the FDA to recognize drug manufacturing site inspections conducted by other global authorities.

Download this complimentary whitepaper outlining the changes made in this agreement to see how this can impact your organization.

Download link will appear once form is submitted.


Your Name (required)

Your Company (required)

Your Email (required)